SEC Form D filing

OrbiMed Asia Partners VI, L.P.

Biotech · Growth · Regulation D 506(b) · NY · Filed May 28, 2026

Offering amount: $850.0M
Exemption: Reg D 506(b)
Issuer state: NY
Filing date: May 28, 2026
Signature date: May 28, 2026
CIK: 0002087034

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Sector: Biotech Month: May 2026 Stage and month: Growth

Summary

Auto-generated

OrbiMed Asia Partners VI is a biotech-focused fund with $850M offering indicating mature growth-stage fund.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.